Delivery Order SPE2DB24D8003-SPE2DB25FJTWL
Award Date
2/24/25
Potential Completion Date
2/25/25
Potential Value
$6.2K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $12,932.87 firm fixed-price contract is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a performance period through May 6, 2024. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, providing a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $6,726.07 firm fixed-price delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a prescription medication. The contract does not have a set-aside designation. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which allows the company to provide a comprehensive...
This federal contract award, valued at $4,508.95, was issued by the Defense Logistics Agency (DLA) to prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a completion date of August 28, 2024. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program,...
This firm-fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of 4565192015 VRAYLAR 1.5 MG CAPSULE 30S. The contract has a ceiling value of $1,894.42 and a period of performance through July 19, 2024. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, providing a comprehensive range of pharmaceutical products, medical supplies, and healthcare...
This federal contract award, valued at $1,797.26, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of 4565441401 VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product, under a firm fixed-price delivery order. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to...
This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBQWZ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $17,018.46, is a firm fixed-price delivery order for the supply of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product. Dakota Drug, Inc. is a key supplier to the DLA, holding a significant single-award Indefinite Delivery Contract (IDC) valued at...
This federal contract award, identified as SPE2DB24D8002 and SPE2DB25FJMUL, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of VRAYLAR 6 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $22,846.43 and a performance period through December 4, 2024. Dakota Drug, Inc. is an experienced federal contractor, holding a significant Indefinite Delivery Contract...
This federal contract award, identified as SPE2DX15D8003|SPE2DX24F7B6M, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,971.93 firm fixed-price delivery order is for the provision of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a completion date of November 9, 2023. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a substantial single-award...
This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBQCC, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The $5,192.94 firm fixed price delivery order is for the provision of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product. Dakota Drug, Inc. is a significant supplier for the DLA Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) as part of the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of the pharmaceutical product VRAYLAR 6 MG CAPSULE 30S. The contract has a ceiling value of $13,656.06 and an ultimate completion date of April 9, 2024. The contract was awarded on April 8, 2024 and does not have a set-aside designation. Dakota Drug, Inc. is a prime contractor with over two...